Samuel Georg Friedrich Leupold
Known title: DirectorCIK: 0001859598
Associated companies
Transaction History
| SLB | ▲ Buy | Grant | 3,428 | $0 | 5/1/2026 | View on chart |
| SLB | ▲ Buy | Grant | 5,714 | $0 | 5/1/2025 | View on chart |
| SLB | ▲ Buy | Grant | 4,001 | $0 | 5/1/2024 | View on chart |
| SLB | ▲ Buy | Grant | 3,850 | $0 | 5/1/2023 | View on chart |
| SLB | ▲ Buy | Grant | 4,871 | $0 | 5/2/2022 | View on chart |
| SLB | ▲ Buy | Grant | 248 | $0 | 8/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
SLB Q3 Earnings Preview: Barclays Lowers Price Target to $66
SLB is preparing for its Q3 earnings release, with analysts expecting a decline in results. Barclays recently maintained an Overweight rating but lowered its price target to $66. This move comes as the stock trades near its 52-week low, reflecting broader market caution and sector-specific pressures.
SLB Q3 Earnings Preview: Barclays Lowers Price Target to $66. SLB is preparing for its Q3 earnings release, with analysts expecting a decline in results. Barclays recently maintained an Overweight rating but lowered its price target to $66. This move comes as the stock trades near its 52-week low, reflecting broader market caution and sector-specific pressures.